WHO ICTRP trial
Comparative study of 2 different doses of magnesium sulfate treatment as a drug…
CTRI/2022/08/045003 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2022/08/045003 |
|---|---|
| Public title | Comparative study of 2 different doses of magnesium sulfate treatment as a drug to prevent fits in patients of eclampsia . |
| Scientific title | Comparison of effectivness of short course of magnesium sulfate versus pritchard regimen of magnesium sulfate as an anticonvulsant in patient of eclampsia |
| Primary sponsor | Dr Smrity Naik |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Countries | India |
| Conditions | Health Condition 1: O159- Eclampsia, unspecified as to timeperiod |
| Interventions | Intervention1: magnesium sulfate: comparision of pritchard regimen {14gm laoding- (4gm IV+10gm IM)+Maintenance 30gm IM (5gm in alternate buttocks 4hrly 6doses)} versus short course {14gm loading + 10gm maintenance (5gm in alternate buttocks… |
| Registration date | Aug 29, 2022 |
| Target size | 100 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: